339 related articles for article (PubMed ID: 21769821)
1. Improving the precision of QT measurements.
Darpo B; Fossa AA; Couderc JP; Zhou M; Schreyer A; Ticktin M; Zapesochny A
Cardiol J; 2011; 18(4):401-10. PubMed ID: 21769821
[TBL] [Abstract][Full Text] [Related]
2. Sample size, power calculations, and their implications for the cost of thorough studies of drug induced QT interval prolongation.
Malik M; Hnatkova K; Batchvarov V; Gang Y; Smetana P; Camm AJ
Pacing Clin Electrophysiol; 2004 Dec; 27(12):1659-69. PubMed ID: 15613131
[TBL] [Abstract][Full Text] [Related]
3. Effect of levetiracetam on cardiac repolarization in healthy subjects: a single-dose, randomized, placebo- and active-controlled, four-way crossover study.
Hulhoven R; Rosillon D; Bridson WE; Meeus MA; Salas E; Stockis A
Clin Ther; 2008 Feb; 30(2):260-70. PubMed ID: 18343264
[TBL] [Abstract][Full Text] [Related]
4. Comparison of manual and automated measurements of the QT interval in healthy volunteers: an analysis of five thorough QT studies.
Fosser C; Duczynski G; Agin M; Wicker P; Darpo B
Clin Pharmacol Ther; 2009 Nov; 86(5):503-6. PubMed ID: 19339965
[TBL] [Abstract][Full Text] [Related]
5. Man versus machine: is there an optimal method for QT measurements in thorough QT studies?
Darpo B; Agin M; Kazierad DJ; Layton G; Muirhead G; Gray P; Jorkasky DK
J Clin Pharmacol; 2006 Jun; 46(6):598-612. PubMed ID: 16707406
[TBL] [Abstract][Full Text] [Related]
6. Sugammadex is not associated with QT/QTc prolongation: methodology aspects of an intravenous moxifloxacin-controlled thorough QT study.
de Kam PJ; van Kuijk J; Smeets J; Thomsen T; Peeters P
Int J Clin Pharmacol Ther; 2012 Aug; 50(8):595-604. PubMed ID: 22735462
[TBL] [Abstract][Full Text] [Related]
7. Statistical characteristics of moxifloxacin-induced QTc effect.
Yan LK; Zhang J; Ng MJ; Dang Q
J Biopharm Stat; 2010 May; 20(3):497-507. PubMed ID: 20358432
[TBL] [Abstract][Full Text] [Related]
8. Comparison of semiautomated and fully automated methods for QT measurement during a thorough QT/QTc study: variability and sample size considerations.
Tyl B; Kabbaj M; Fassi B; De Jode P; Wheeler W
J Clin Pharmacol; 2009 Aug; 49(8):905-15. PubMed ID: 19542314
[TBL] [Abstract][Full Text] [Related]
9. Comparing QT interval variability of semiautomated and high-precision ECG methodologies in seven thorough QT studies-implications for the power of studies intended for definitive evaluation of a drug's QT effect.
Meiser K; Jordaan P; Latypova S; Darpo B
Ann Noninvasive Electrocardiol; 2017 Jan; 22(1):. PubMed ID: 27995684
[TBL] [Abstract][Full Text] [Related]
10. Lack of effect of aprepitant or its prodrug fosaprepitant on QTc intervals in healthy subjects.
Marbury TC; Jin B; Panebianco D; Murphy MG; Sun H; Evans JK; Han TH; Constanzer ML; Dru J; Shadle CR
Anesth Analg; 2009 Aug; 109(2):418-25. PubMed ID: 19608812
[TBL] [Abstract][Full Text] [Related]
11. Diurnal pattern of QTc interval: how long is prolonged? Possible relation to circadian triggers of cardiovascular events.
Molnar J; Zhang F; Weiss J; Ehlert FA; Rosenthal JE
J Am Coll Cardiol; 1996 Jan; 27(1):76-83. PubMed ID: 8522713
[TBL] [Abstract][Full Text] [Related]
12. Systematic comparisons of electrocardiographic morphology increase the precision of QT interval measurement.
Hnatkova K; Smetana P; Toman O; Bauer A; Schmidt G; Malik M
Pacing Clin Electrophysiol; 2009 Jan; 32(1):119-30. PubMed ID: 19140922
[TBL] [Abstract][Full Text] [Related]
13. Effects of a supratherapeutic dose of investigational orally inhaled dihydroergotamine (MAP0004) on QT interval: a randomized, double-blind, active- and placebo-controlled crossover study in healthy volunteers.
Kori S; Kellerman DJ; Voloshko P; Haugen G
Clin Ther; 2012 Sep; 34(9):1920-8. PubMed ID: 22917853
[TBL] [Abstract][Full Text] [Related]
14. Effect of a single oral dose of moxifloxacin (400 mg and 800 mg) on ventricular repolarization in healthy subjects.
Démolis JL; Kubitza D; Tennezé L; Funck-Brentano C
Clin Pharmacol Ther; 2000 Dec; 68(6):658-66. PubMed ID: 11180026
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the effects of bitopertin (RG1678) on cardiac repolarization: a thorough corrected QT study in healthy male volunteers.
Hofmann C; Banken L; Hahn M; Swearingen D; Nagel S; Martin-Facklam M
Clin Ther; 2012 Oct; 34(10):2061-71. PubMed ID: 22980315
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of vardenafil and sildenafil on cardiac repolarization.
Morganroth J; Ilson BE; Shaddinger BC; Dabiri GA; Patel BR; Boyle DA; Sethuraman VS; Montague TH
Am J Cardiol; 2004 Jun; 93(11):1378-83, A6. PubMed ID: 15165918
[TBL] [Abstract][Full Text] [Related]
17. Measuring the effects of supratherapeutic doses of levofloxacin on healthy volunteers using four methods of QT correction and periodic and continuous ECG recordings.
Noel GJ; Goodman DB; Chien S; Solanki B; Padmanabhan M; Natarajan J
J Clin Pharmacol; 2004 May; 44(5):464-73. PubMed ID: 15102866
[TBL] [Abstract][Full Text] [Related]
18. Raltegravir thorough QT/QTc study: a single supratherapeutic dose of raltegravir does not prolong the QTcF interval.
Iwamoto M; Kost JT; Mistry GC; Wenning LA; Breidinger SA; Marbury TC; Stone JA; Gottesdiener KM; Bloomfield DM; Wagner JA
J Clin Pharmacol; 2008 Jun; 48(6):726-33. PubMed ID: 18441333
[TBL] [Abstract][Full Text] [Related]
19. Creation of a knowledge management system for QT analyses.
Tornøe CW; Garnett CE; Wang Y; Florian J; Li M; Gobburu JV
J Clin Pharmacol; 2011 Jul; 51(7):1035-42. PubMed ID: 20978278
[TBL] [Abstract][Full Text] [Related]
20. Cardiac repolarization with Gabapentin enacarbil in a randomized, double-blind, placebo- and active-controlled, crossover thorough QT/QTc study in healthy adults.
Davy M; Upward J; Arumugham T; Twomey C; Chen C; Stier B
Clin Ther; 2013 Dec; 35(12):1964-74. PubMed ID: 24290737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]